Editas Germline Genome Editing Governance Weighed by International Commission Premium The NAM, NAS, and Royal Society have formed a commission to develop a framework on the proper use of genome editing, and convened its first meeting in Washington, DC, this week. Editas Medicine Licenses New CRISPR Enzyme From Integrated DNA Technologies Editas exclusively licensed the new enzyme, Alt-R Cas12a (Cpf1) Ultra, a mutant of Acidaminococcus sp. BV3L6 Cas12a (Cpf1), from IDT for therapeutic applications. New IDT Multiplexed Target Amplification Technology Promises High Specificity Premium Early-access users have used IDT's rhAmpSeq technology to create genetic marker maps for plants and to validate off target events in gene editing. Federal Court Hands Broad Institute Victory in CRISPR Patent Fight Against UC Berkeley The court upheld a judgement of no interference-in-fact from the Patent Trial and Appeal Board, leaving the Broad in control of key CRISPR IP. Editas Medicine to Provide Broad Institute With up to $125M in CRISPR Funding In exchange, Editas has the exclusive right to be the first to negotiate for licenses to genome-editing inventions that arise from the sponsored research. May 17, 2018 Gene Editing Startup Beam Therapeutics Launches With $87M in Series A Funds Nov 15, 2017 Senate Committee Holds Hearing on CRISPR Science, Ethical Concerns, Regulatory Approaches Mar 17, 2017 Editas Prices $90M Public Stock Offering Mar 15, 2017 Editas Plans Common Stock Offering Mar 14, 2017 Editas, Allergan Ink $90M CRISPR-Based Eye Drug Deal Feb 16, 2017 Broad Institute Wins CRISPR Patent Interference; IP Fight Not Over Dec 19, 2016 Editas Medicine Inks Licensing Deals for CRISPR IP Aug 9, 2016 Editas, Adverum Biotechnologies Collaborate on Delivering Genome-Editing Therapies for Eye Diseases Aug 3, 2016 Editas Licenses Engineered Cas9 Variants From MGH Jul 28, 2016 Editas Inks Collaboration, Development Deal With Italian Gene Therapy Institute May 16, 2016 Editas Inks $5M Collaboration With Cystic Fibrosis Foundation Therapeutics Breaking News In Brief This Week: Veracyte, Danaher, Chembio Diagnostics, and More Decode Genetics Plasma Proteome Study Improves Understanding of Disease Pathogenesis Euformatics Gains CE-IVD Mark for OmnomicsNGS People in the News: New Appointments at SomaLogic, 23andMe, Pacific Biosciences, More New Products Posted to GenomeWeb: GenDx, Eurofins Technologies, Codex DNA, More Variant Identified in Amish Population Appears to Protect From Cardiovascular Disease The Scan Steps for Quick Review The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal. Moving Away From Using Term 'Race' A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports. Point of the Program The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question. Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.